المؤلفون: Annette Fontaine, Anup Kasi, Jourdain Hayward, Tareq Al Baghdadi, Manisha Shah, Melissa Plets, Megan Othus, Razelle Kurzrock, Edward Mayerson, Zoran Gatalica, Francis J. Giles, Christopher W. Ryan, Donna E. Hansel, Christine M. McLeod, Sandip Pravin Patel, Elad Sharon, Helen X. Chen, Marc Matrana, W. Michael Korn, Preet Paul Singh, Young Kwang Chae, Charles D. Blanke

المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research, vol 26, iss 10
Clin Cancer Res

مصطلحات موضوعية: Male, 0301 basic medicine, Cancer Research, Programmed Cell Death 1 Receptor, Phases of clinical research, Neuroendocrine tumors, Gastroenterology, 0302 clinical medicine, Antineoplastic Combined Chemotherapy Protocols, 80 and over, Clinical endpoint, CTLA-4 Antigen, Prospective Studies, Prospective cohort study, Cancer, Aged, 80 and over, Middle Aged, Prognosis, Survival Rate, Neuroendocrine Tumors, Nivolumab, Oncology, 6.1 Pharmaceuticals, 030220 oncology & carcinogenesis, Female, medicine.drug, Adult, medicine.medical_specialty, Clinical Trials and Supportive Activities, Oncology and Carcinogenesis, Ipilimumab, Article, Pancreatic Cancer, 03 medical and health sciences, Rare Diseases, Clinical Research, Internal medicine, medicine, Humans, Oncology & Carcinogenesis, Intermediate Grade, Survival rate, Aged, business.industry, Neurosciences, Evaluation of treatments and therapeutic interventions, medicine.disease, 030104 developmental biology, Digestive Diseases, business, Follow-Up Studies

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af0a5916b106134919751addb6c490a4Test
https://doi.org/10.1158/1078-0432.ccr-19-3356Test

المؤلفون: Yaozhong Zhao, Jianda Hu, Jun Luo, Yuqin Song, Liling Zhang, Yan-Yan Liu, Jie Jin, Xinchuan Chen, Jifeng Feng, Jun Zhu, Qingyuan Zhang, Weiwei Wang, Haiwen Huang, Junning Cao, Jianqiu Wu, Chun Xia Chen, Hongwei Xue, T. Lin

المصدر: Clinical Cancer Research. 25:7363-7369

مصطلحات موضوعية: Adult, Male, 0301 basic medicine, Cancer Research, medicine.medical_specialty, Maximum Tolerated Dose, Programmed Cell Death 1 Receptor, Phases of clinical research, Salvage therapy, Antibodies, Monoclonal, Humanized, Gastroenterology, Young Adult, 03 medical and health sciences, 0302 clinical medicine, Autologous stem-cell transplantation, Refractory, Internal medicine, medicine, Clinical endpoint, Humans, Adverse effect, Survival rate, Aged, Salvage Therapy, business.industry, Middle Aged, Hodgkin Disease, Survival Rate, Treatment Outcome, 030104 developmental biology, Oncology, Drug Resistance, Neoplasm, 030220 oncology & carcinogenesis, Monoclonal, Female, Patient Safety, Neoplasm Recurrence, Local, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad3780a7b6f8eba39109ae1dbee11028Test
https://doi.org/10.1158/1078-0432.ccr-19-1680Test

المؤلفون: Michael J. Schell, Nikhil I. Khushalani, Howard L. McLeod, Vincent A. Miller, Kenneth Y. Tsai, Andrew S. Brohl, Jeffery S. Russell, Zeynep Eroglu, Jane L. Messina, Vernon K. Sondak, Todd C. Knepper, Ethan Sokol, Lee A. Albacker, Meagan Montesion, Garrett M. Frampton, James A. DeCaprio

المصدر: Clinical Cancer Research. 25:5961-5971

مصطلحات موضوعية: Adult, Male, 0301 basic medicine, Cancer Research, Skin Neoplasms, Immune checkpoint inhibitors, medicine.medical_treatment, Programmed Cell Death 1 Receptor, Merkel cell polyomavirus, Genomics, Disease, Biology, B7-H1 Antigen, Article, 03 medical and health sciences, Antineoplastic Agents, Immunological, 0302 clinical medicine, Biomarkers, Tumor, medicine, Ultraviolet light, Humans, Aged, Aged, 80 and over, Merkel cell carcinoma, High-Throughput Nucleotide Sequencing, Immunotherapy, Middle Aged, medicine.disease, biology.organism_classification, Carcinoma, Merkel Cell, Survival Rate, genomic DNA, Treatment Outcome, 030104 developmental biology, Oncology, 030220 oncology & carcinogenesis, Mutation, Cancer research, Female

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60719333bb5486fadc38b774e91d057eTest
https://doi.org/10.1158/1078-0432.ccr-18-4159Test

المؤلفون: Jeffery S. Russell, Shanmugasundaram Ramkumar, Everett E. Vokes, Robert L. Ferris, Makoto Tahara, Maura L. Gillison, Lisa Licitra, Mark Lynch, Robert I. Haddad, Joël Guigay, Caroline Even, Nabil F. Saba, Kevin J. Harrington, Fernando Concha-Benavente, Jérôme Fayette, Li Li, Peter Brossart, George R. Blumenschein, A. Dimitrios Colevas

المصدر: Clin Cancer Res

مصطلحات موضوعية: Adult, 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, medicine.medical_treatment, Programmed Cell Death 1 Receptor, Cetuximab, Article, law.invention, 03 medical and health sciences, Antineoplastic Agents, Immunological, 0302 clinical medicine, Randomized controlled trial, law, Internal medicine, Clinical endpoint, medicine, Humans, Neoplasm Metastasis, Survival rate, Aged, Aged, 80 and over, Chemotherapy, Squamous Cell Carcinoma of Head and Neck, business.industry, Immunotherapy, Middle Aged, ErbB Receptors, Survival Rate, Clinical trial, Nivolumab, 030104 developmental biology, Head and Neck Neoplasms, 030220 oncology & carcinogenesis, Neoplasm Recurrence, Local, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a754089cc56f4bc972d5ecdf0accbd84Test
https://doi.org/10.1158/1078-0432.ccr-18-3944Test

المؤلفون: Alessia Covre, Giovanni Amato, Michele Maio, Francesca Finotello, James N. Lowder, Amelie Nemc, Santa Monterisi, Zlatko Trajanoski, Florent Petitprez, Anna Maria Di Giacomo, Sandra Coral, Andrea Lazzeri, Laetitia Lacroix, Ornella Cutaia, Riccardo Danielli, Luca Sigalotti, Wolf H. Fridman, Monica Valente, Carolina Fazio, Mohammad Azab, Andrea Anichini, Diana Giannarelli, Christoph Bock, Dietmar Rieder, Clelia Miracco, Catherine Sautès-Fridman, Aram Oganesian

المصدر: Clinical Cancer Research

مصطلحات موضوعية: 0301 basic medicine, Adult, Male, Cancer Research, medicine.medical_specialty, Maximum Tolerated Dose, Programmed Cell Death 1 Receptor, Ipilimumab, CD8-Positive T-Lymphocytes, Gastroenterology, 03 medical and health sciences, 0302 clinical medicine, Pharmacokinetics, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Neoplasm Metastasis, Adverse effect, Survival rate, Melanoma, Aged, Neoplasm Staging, Aged, 80 and over, business.industry, Cancer, DNA Methylation, Middle Aged, medicine.disease, 3. Good health, Clinical trial, Gene Expression Regulation, Neoplastic, Survival Rate, 030104 developmental biology, Treatment Outcome, Oncology, Tolerability, 030220 oncology & carcinogenesis, Azacitidine, Female, Patient Safety, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf6bf5326d9ecad92fa6c06a0e46a84eTest